Table 3.
Bacterial infection | p valuea | Sens (95% CIb) | Spec (95% CIb) | PPV (95% CIc) | NPV (95% CIc) | |||
---|---|---|---|---|---|---|---|---|
Yes | No | |||||||
IL6 > 60 and PCT > 0.25 | T0 | 14/15 | 23/49 | 0.01 | 93.3% (68.1–99.8) | 53.1% (38.3–67.5) | 37.8% (30.5–45.8) | 96.3% (79.4–99.4) |
T1 | 9/10 | 12/35 | 0.002 | 90.0% (55.5–99.8) | 65.7% (47.8–80.9) | 42.9% (31.2–55.4) | 95.8% (77.9–99.3) | |
IL6 > 60 or PCT > 0.25 | T0 | 15/15 | 37/49 | 0.033 | 100% (78.2–100) | 24.5% (13.3–38.9) | 28.8% (25.7–32.3) | 100% |
T1 | 10/10 | 26/35 | 0.073 | 100% (69.2–100) | 25.7% (12.5–43.3) | 27.7% (24.0–31.9) | 100% |
Combinations of IL-6 and PCT and their predictive value are given at T0 (the time of presentation) and T1 (12 to 24 h after presentation). In the first decision rule, both biomarkers are above the cutoff value. In the second decision rule, either one of the biomarkers is above the cutoff value
IL-6 interleukin-6, PCT procalcitonin, Sens sensitivity, Spec specificity, PPV positive predictive value, NPV negative predictive value, CI confidence interval
aChi-square test
bExact Clopper-Pearson CI
cStandard logit CI